These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38243959)

  • 1. Nuclear Factor Kappa B: A Nobel Therapeutic Target of FlavonoidsAgainst Parkinson's Disease.
    Singh NK; Singh A; Mayank
    Comb Chem High Throughput Screen; 2024; 27(14):2062-2077. PubMed ID: 38243959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.
    Singh SS; Rai SN; Birla H; Zahra W; Rathore AS; Singh SP
    Neurotox Res; 2020 Mar; 37(3):491-507. PubMed ID: 31823227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca
    Leandrou E; Chalatsa I; Anagnostou D; Machalia C; Semitekolou M; Filippa V; Makridakis M; Vlahou A; Anastasiadou E; Vekrellis K; Emmanouilidou E
    Transl Neurodegener; 2024 Feb; 13(1):11. PubMed ID: 38378800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway.
    Meng HW; Shen ZB; Meng XS; Leng-Wei ; Yin ZQ; Wang XR; Zou TF; Liu ZG; Wang TX; Zhang S; Chen YL; Yang XX; Li QS; Duan YJ
    Bioorg Chem; 2023 Sep; 138():106654. PubMed ID: 37300959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway.
    Cai M; Zhuang W; Lv E; Liu Z; Wang Y; Zhang W; Fu W
    Neurochem Int; 2022 Jan; 152():105221. PubMed ID: 34780806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.
    Bhusal CK; Uti DE; Mukherjee D; Alqahtani T; Alqahtani S; Bhattacharya A; Akash S
    Parkinsonism Relat Disord; 2023 Oct; 115():105799. PubMed ID: 37633805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincamine alleviates brain injury by attenuating neuroinflammation and oxidative damage in a mouse model of Parkinson's disease through the NF-κB and Nrf2/HO-1 signaling pathways.
    Wang P; Chen C; Shan M
    J Biochem Mol Toxicol; 2024 May; 38(5):e23714. PubMed ID: 38629493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EriB targeted inhibition of microglia activity attenuates MPP
    Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
    Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
    Çınar E; Tel BC; Şahin G
    Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active ingredients of Chinese medicine with immunomodulatory properties: NF-κB pathway and Parkinson's disease.
    Song J; Zhao Y; Shan X; Luo Y; Hao N; Zhao L
    Brain Res; 2024 Jan; 1822():148603. PubMed ID: 37748570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Flavonoids Against Parkinson's Disease.
    Jung UJ; Kim SR
    J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steppogenin Isolated from Cudrania tricuspidata Shows Antineuroinflammatory Effects via NF-κB and MAPK Pathways in LPS-Stimulated BV2 and Primary Rat Microglial Cells.
    Kim DC; Quang TH; Oh H; Kim YC
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29207498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration.
    Dolatshahi M; Ranjbar Hameghavandi MH; Sabahi M; Rostamkhani S
    Eur J Neurosci; 2021 Apr; ():. PubMed ID: 33884689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease.
    Zhang C; Zhou J; Zhuo L; Zhang W; Lv L; Zhu L; Zhang J; Feng F; Liu W; Han L; Liao W
    J Ethnopharmacol; 2024 Oct; 333():118391. PubMed ID: 38797377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.